ContractClinical Service Agreement • October 3rd, 2017
Contract Type FiledOctober 3rd, 2017Clinical Service Agreement in support of a Clinical Site This is an Agreement between the NEMOCNICE NA HOMOLCE, with its registered office at Roentgenova 37/2, Praha 5 - Motol Zip Code: 150 30, Czech Republic, company Id.: 00023884, tax ID: CZ00023884, represented by Dr. Ing Ivanem Olivou, director of hospital (hereinafter the “Provider”) and SOTIO a.s., with its address at Jankovcova 1518/2, 170 00 Praha 7, ID: 24662623, tax ID: CZ24662623, registered in the Companies Register maintened by the Municipal Court in Prague, Section B, Insert 16136, represented by Ing. Richard Kapsa and Mgr. Vladimír Prunner. (hereinafter the "Sponsor"). "A phase I/II, single-arm clinical trial to evaluate the safety and immune activation of the combination of DCVAC/PCa, an active cellular immunotherapy, and ONCOS-102, an immune-priming adenovirus, in men with advanced metastatic castration-resistant prostate cancer“ (the "Protocol"). Protocol forms Annex 1 to this Agreement. Drugs are evaluated under